$510,000 of BRIDGEBIO PHARMA INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Orphan drug policies General issues and provisions related to PBM Reform General issues and provisions related to tariffs H.R.1532 and S.822 - Scientific EXPERT Act Priority for Pediatric Cures Act (H.R.10359)"
You can find more data on corporate lobbying on Quiver Quantitative.
BBIO Congressional Stock Trading
Members of Congress have traded $BBIO stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BBIO stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 05/11, 04/29 and 1 sale worth up to $15,000 on 09/29.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
BBIO Insider Trading Activity
BBIO insiders have traded $BBIO stock on the open market 43 times in the past 6 months. Of those trades, 0 have been purchases and 43 have been sales.
Here’s a breakdown of recent trading of $BBIO stock by insiders over the last 6 months:
- JENNIFER E. COOK has made 0 purchases and 6 sales selling 278,192 shares for an estimated $21,920,434.
- NEIL KUMAR (Chief Executive Officer) has made 0 purchases and 28 sales selling 161,083 shares for an estimated $11,643,908.
- ANDREA ELLIS sold 17,167 shares for an estimated $1,442,028
- RANDAL W. SCOTT has made 0 purchases and 4 sales selling 10,000 shares for an estimated $671,455.
- HANNAH VALANTINE has made 0 purchases and 2 sales selling 5,004 shares for an estimated $341,523.
- MARICEL APULI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 4,000 shares for an estimated $303,280.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
BBIO Hedge Fund Activity
We have seen 243 institutional investors add shares of BBIO stock to their portfolio, and 227 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 3,920,601 shares (-27.6%) from their portfolio in Q2 2026, for an estimated $292,006,362
- WELLINGTON MANAGEMENT GROUP LLP added 2,824,971 shares (+113.7%) to their portfolio in Q2 2026, for an estimated $210,403,840
- JPMORGAN CHASE & CO added 2,397,995 shares (+inf%) to their portfolio in Q2 2026, for an estimated $178,602,667
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,075,272 shares (-54.6%) from their portfolio in Q2 2026, for an estimated $154,566,258
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. removed 1,900,000 shares (-55.1%) from their portfolio in Q2 2026, for an estimated $141,512,000
- VIKING GLOBAL INVESTORS LP removed 1,893,215 shares (-16.0%) from their portfolio in Q2 2026, for an estimated $141,006,653
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,709,417 shares (+inf%) to their portfolio in Q2 2026, for an estimated $127,317,378
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
BBIO Price Targets
Multiple analysts have issued price targets for $BBIO recently. We have seen 7 analysts offer price targets for $BBIO in the last 6 months, with a median target of $102.0.
Here are some recent targets:
- Salim Syed from Mizuho set a target price of $96.0 on 06/16/2026
- Whitney Ijem from Canaccord Genuity set a target price of $104.0 on 06/03/2026
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $110.0 on 05/28/2026
- Sean Laaman from Morgan Stanley set a target price of $98.0 on 05/28/2026
- Eric Joseph from Citigroup set a target price of $82.0 on 05/19/2026
- Cory Kasimov from Evercore ISI Group set a target price of $130.0 on 05/08/2026
- Danielle Brill from Truist Securities set a target price of $102.0 on 04/29/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
